Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
Clinical trial NCT01933711 · UNKNOWN
Trial details
- NCT number
- NCT01933711
- Sponsor
- University Hospital Heidelberg
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.